Roca-Vinardell A, Berrocoso E, Llorca-Torralba M, García-Partida J A, Gibert-Rahola J, Mico J A
Neuropsychopharmacology and Psychobiology Research Group, Department of Neuroscience, University of Cadiz, Cadiz, Spain.
Neuropsychopharmacology and Psychobiology Research Group, Department of Psychology, University of Cadiz, Cadiz, Spain.
Neurobiol Pain. 2018 Feb 1;3:15-21. doi: 10.1016/j.ynpai.2018.01.004. eCollection 2018 Jan-Jul.
The mechanism of analgesic action of paracetamol (acetominophen) remains still unknown. However, a relationship between serotonergic system and the effect of paracetamol has been previously demonstrated. The serotonin activity in the brainstem is primarily under the control of 5-HT somatodendritic receptors, although some data also suggest the involvement of 5-HT receptors. To determine whether the 5-HT and 5-HT receptors are involved in the antinociceptive effect of paracetamol, we evaluated the effect of paracetamol (0.125-1 g/kg i.p.) followed by different antagonists [WAY 100,635 (0.8 mg/kg s.c.) and SB 216,641 (0.8 mg/kg s.c.)] or agonists [8-OH-DPAT (0.125 mg/kg s.c.) and CP 93,129 (0.125 mg/kg s.c.)] of 5-HT and 5-HT receptors, respectively, in the rat model of formalin-induced pain. We demonstrated that paracetamol administration showed a dose-dependent antinociceptive effect in the formalin test. WAY 100,635 (5-HT antagonist) induced an increase in the antinociceptive effect of paracetamol at 250 mg/kg doses. Conversely, 8-OH-DPAT (5-HT agonist) decreased the antinociceptive effect of paracetamol at 500-1000 mg/kg doses. However, SB216641 (5-HT antagonist) modified weakly the antinociceptive effect of paracetamol at 250 mg/kg doses and CP 93,129 (5-HT agonist) not produce a clear effect in the antinociceptive effect of paracetamol. These results suggest that the antinociceptive effect of paracetamol can be enhanced mainly by compounds having 5-HT antagonist properties in the formalin test and maybe by 5-HT receptors antagonists.
对乙酰氨基酚(扑热息痛)的镇痛作用机制仍然未知。然而,先前已证明血清素能系统与对乙酰氨基酚的作用之间存在关联。脑干中的血清素活性主要受5-羟色胺躯体树突受体的控制,尽管一些数据也表明5-羟色胺受体也参与其中。为了确定5-羟色胺和5-羟色胺受体是否参与对乙酰氨基酚的抗伤害感受作用,我们评估了对乙酰氨基酚(0.125 - 1 g/kg腹腔注射)之后分别给予不同的5-羟色胺和5-羟色胺受体拮抗剂[WAY 100,635(0.8 mg/kg皮下注射)和SB 216,641(0.8 mg/kg皮下注射)]或激动剂[8-OH-DPAT(0.125 mg/kg皮下注射)和CP 93,129(0.125 mg/kg皮下注射)]在福尔马林诱导的疼痛大鼠模型中的作用。我们证明,在福尔马林试验中,给予对乙酰氨基酚显示出剂量依赖性的抗伤害感受作用。WAY 100,635(5-羟色胺拮抗剂)在250 mg/kg剂量时可增强对乙酰氨基酚的抗伤害感受作用。相反,8-OH-DPAT(5-羟色胺激动剂)在500 - 1000 mg/kg剂量时可降低对乙酰氨基酚的抗伤害感受作用。然而,SB216641(5-羟色胺拮抗剂)在250 mg/kg剂量时对乙酰氨基酚的抗伤害感受作用影响较弱,而CP 93,129(5-羟色胺激动剂)对对乙酰氨基酚的抗伤害感受作用未产生明显影响。这些结果表明,在福尔马林试验中,对乙酰氨基酚的抗伤害感受作用主要可通过具有5-羟色胺拮抗剂特性的化合物增强,可能还通过5-羟色胺受体拮抗剂增强。